Global Leukemia Cancer Market Research and Forecast 2018-2023

  • ID: 4471523
  • Report
  • Region: Global
  • Orion Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • Affichem
  • Bristol-Myers Squibb
  • Clavis Pharma Asa
  • Eisai Co. Ltd.
  • Erytech Pharma
  • Genzyme Corporation
  • MORE
Global leukemia cancer market is expected to show high growth during 2018-2023. High incidence rate of blood cancers and rise in incidence of leukaemia across the globe will drive the leukemia market. Leukaemia cancer starts in blood-forming tissue, usually the bone marrow. It causes the over-production of abnormal white blood cells. Leukaemia is commonly caused due to exposure to radiations, unhealthy lifestyle habits, and environmental factors. Increasing investments in the healthcare sector and rising development of new drugs and therapeutics will drive the market in near future. According to WHO, globally the leukemia cancer is considered to be the most common blood cancer. Many companies are developing innovative medicines targeted against leukemia, lymphoma, myeloma, and other blood cancers. These newly developed medications are currently in human clinical trials or being reviewed by the US FDA.

The global leukaemia cancers market is analysed on the basis of the geographical regions that are contributing significantly towards the growth of the market. The North America market for leukemia is predicted to experience high growth throughout the forecast period due to high incidence rate of blood cancers in the US and increasing investments in R&D to explore the leukemia market. In addition, Europe have been significantly contributing in the market attributed to the increasing investments in the healthcare sector and rising development of new drugs and therapeutics. In addition, the advancements in technology and favourable government policies and initiatives are projected to strengthen leukemia market in Europe during the forecast period. Furthermore, the development of healthcare infrastructure in the emerging economies is considered to generate promising development prospects for the market players in Asia Pacific. The increasing contribution from China, India, and Japan and the rising investments for R&D programs are projected to encourage the growth of the leukemia market in Asia Pacific during 2018-2023.

Some of the leukaemia cancer market players such as Biogen, Inc., Glaxosmithkline PLC, Novartis International AG, Pfizer Inc, Roche Holding AG, Takeda Oncology and Teva Pharmaceuticals are contributing significantly into the growth of the market. The companies perform different strategies such as product launch, acquisition, partnership & collaboration to stay competitive in the market. For instance, in 2017, Novartis received the FDA approval for a CAR-T cell therapy, Kymriah (TM) (CTL019), for children and young adults with B-cell ALL (Acute Lymphoblastic Leukemia) that is refractory or has relapsed at least twice.

Market Segmentation:
  • Global leukaemia cancer market research and analysis by type
  • Global leukaemia cancer market research and analysis by diagnostic and monitor
  • Global leukaemia cancer market research and analysis by treatment
The Report covers:
  • Comprehensive research methodology of global leukemia cancer market.
  • This report also includes detailed and extensive market overview with analyst insights & key market trends.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global leukemia cancer market.
  • Insights about market determinants which are stimulating the global leukemia cancer market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Affichem
  • Bristol-Myers Squibb
  • Clavis Pharma Asa
  • Eisai Co. Ltd.
  • Erytech Pharma
  • Genzyme Corporation
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World

3. Market Determinant
3.1. Motivators
3.1.1. High Incidence Rate of Blood Cancers in the Us
3.1.2. Rising Cases of Leukaemia Due to Change in Lifestyle and ENVironment
3.1.3. Increasing Investments in R&D to Explore the Leukemia Market
3.1.4. Development of New Drugs and Therapeutics
3.2. Restraints
3.2.1. Adverse Effects of Treatment
3.2.2. High Cost of Treatment
3.3. Opportunities
3.3.1. Government Initiatives to Curb Cancer
3.3.2. Emergence of Innovative Therapeutics
3.3.3. Improving Cancer Care Rates

4. Market Segmentation
4.1. Global Leukemia Cancer Market on the Basis of Type
4.1.1. Acute Myeloid Leukaemia (Aml)
4.1.2. Chronic Myeloid Leukaemia (Cml)
4.1.3. Acute Lymphoblastic Leukaemia (All)
4.1.4. Chronic Lymphocytic Leukaemia (Cll)
4.2. Global Leukemia Cancer Market on the Basis of Diagnose and Monitor
4.2.1. Blood Tests
4.2.2. Bone Marrow Tests
4.2.3. Imaging Tests
4.2.4. Lymph Node Biopsy
4.2.5. Lumbar Puncture
4.2.6. Urine Tests
4.3. Global Leukemia Cancer Market on the Basis of Treatment
4.3.1. Chemotherapy
4.3.2. Radiation Therapy
4.3.3. Targeted Therapy
4.3.4. Biological Therapy
4.3.5. Stem Cell Transplant

5. Competitive Landscape
5.1. Market Strategies
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Actinium Pharmaceuticals Inc.
7.2. Affichem
7.3. Biogen Idec Inc.
7.4. Bristol-Myers Squibb
7.5. Celgene Corporation
7.6. Clavis Pharma Asa
7.7. Daiichi Sankyo
7.8. Eisai Co. Ltd.
7.9. Epizyme Inc.
7.10. Erytech Pharma
7.11. Genmab A/S
7.12. Genzyme Corporation
7.13. Glaxosmithkline PLC
7.14. Novartis International Ag
7.15. Pfizer Inc
7.16. Roche Holding Ag
7.17. Spectrum Pharmaceuticals Inc.
7.18. Sunesis Pharmaceuticals Inc
7.19. Takeda Oncology
7.20. Teva Pharmaceuticals

List of Tables:
Table 1 Global Leukemia Cancer Market Research and Analysis by Type, 2017-2023 ($ Million)
Table 2 Global Acute Myeloid Leukaemia (Aml) Market Research and Analysis, 2017-2023 ($ Million)
Table 3 Global Chronic Myeloid Leukaemia (Cml) Market Research and Analysis, 2017-2023 ($ Million)
Table 4 Global Acute Lymphoblastic Leukaemia (All) Market Research and Analysis, 2017-2023 ($ Million)
Table 5 Global Chronic Lymphocytic Leukaemia (Cll) Market Research and Analysis, 2017-2023 ($ Million)
Table 6 Global Leukemia Cancer Market Research and Analysis by Diagnose and Monitor, 2017-2023 ($ Million)
Table 7 Global Blood Tests Market Research and Analysis, 2017-2023 ($ Million)
Table 8 Global Bone Marrow Tests Market Research and Analysis, 2017-2023 ($ Million)
Table 9 Global Imaging Tests Market Research and Analysis, 2017-2023 ($ Million)
Table 10 Global Lymph Node Biopsy Market Research and Analysis, 2017-2023 ($ Million)
Table 11 Global Lumbar Puncture Market Research and Analysis, 2017-2023 ($ Million)
Table 12 Global Urine Tests Market Research and Analysis, 2017-2023 ($ Million)
Table 13 Global Leukemia Cancer Market Research and Analysis by Treatment, 2017-2023 ($ Million)
Table 14 Global Chemotherapy Market Research and Analysis, 2017-2023 ($ Million)
Table 15 Global Radiation Therapy Market Research and Analysis, 2017-2023 ($ Million)
Table 16 Global Targeted Therapy Market Research and Analysis, 2017-2023 ($ Million)
Table 17 Global Biological Therapy Market Research and Analysis, 2017-2023 ($ Million)
Table 18 Global Stem Cell Transplant Market Research and Analysis, 2017-2023 ($ Million)
Table 19 Global Leukemia Cancer Market Research and Analysis by Geography, 2017-2023 ($ Million)
Table 20 North American Leukemia Cancer Market Research and Analysis by Country, 2017-2023 ($ Million)
Table 21 North American Leukemia Cancer Market Research and Analysis by Type, 2017-2023 ($ Million)
Table 22 North American Leukemia Cancer Market Research and Analysis by Diagnosis and Monitor 2017-2023 ($ Million)
Table 23 North American Leukemia Cancer Market Research and Analysis by Treatment 2017-2023 ($ Million)
Table 24 European Leukemia Cancer Market Research and Analysis by Country, 2017-2023 ($ Million)
Table 25 European Leukemia Cancer Market Research and Analysis by Type, 2017-2023 ($ Million)
Table 26 European Leukemia Cancer Market Research and Analysis by Diagnosis and Monitor, 2017-2023 ($ Million)
Table 27 European Leukemia Cancer Market Research and Analysis by Treatment, 2017-2023 ($ Million)
Table 28 APAC Leukemia Cancer Market Research and Analysis by Country, 2017-2023, ($ Million)
Table 29 APAC Leukemia Cancer Market Research and Analysis by Type, 2017-2023 ($ Million)
Table 30 APAC Leukemia Cancer Market Research and Analysis by Diagnose and Monitor, 2017-2023, ($ Million)
Table 31 APAC Leukemia Cancer Market Research and Analysis by Treatment 2017-2023, ($ Million)
Table 32 Row Leukemia Cancer Market Research and Analysis by Type 2017-2023 ($ Million)
Table 33 Row Leukemia Cancer Market Research and Analysis by Diagnose and Monitor, 2017-2023 ($ Million)
Table 34 Row Leukemia Cancer Market Research and Analysis by Treatment, 2017-2023 ($ Million)

List of Figures:
Figure 1 Global Leukemia Cancer Market Share by Type, 2017 vs 2023 (%)
Figure 2 Global Leukemia Cancer Market Share by Diagnose and Monitor, 2017 vs 2023 (%)
Figure 3 Global Leukemia Cancer Market Share by Treatment, 2017 vs 2023 (%)
Figure 4 Global Leukemia Cancer Market Share by Geography, 2017 vs 2023 (%)
Figure 5 North America Leukemia Cancer Market Share by Country, 2017 -2023 (%)
Figure 6 US Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 7 Canada Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 8 European Leukemia Cancer Market Share by Country, 2017 vs 2023 (%)
Figure 9 UK Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 10 France Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 11 Germany Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 12 Italy Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 13 Spain Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 14 ROE Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 15 Asia Pacific Leukemia Cancer Market Share by Country, 2017 vs 2023 (%)
Figure 16 India Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 17 China Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 18 Japan Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 19 RoAPAC Leukemia Cancer Market Size, 2017-2023 ($ Million)
Figure 20 Rest of the World Leukemia Cancer Market Size, 2017-2023 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Actinium Pharmaceuticals Inc.
  • Affichem
  • Biogen Idec Inc.
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Clavis Pharma Asa
  • Daiichi Sankyo
  • Eisai Co. Ltd.
  • Epizyme Inc.
  • Erytech Pharma
  • Genmab A/S
  • Genzyme Corporation
  • Glaxosmithkline Plc
  • Novartis International Ag
  • Pfizer Inc
  • Roche Holding Ag
  • Spectrum Pharmaceuticals Inc.
  • Sunesis Pharmaceuticals Inc
  • Takeda Oncology
  • Teva Pharmaceuticals
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll